• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Neuraxpharm Launches European Campaign to Increase Awareness of Medical Cannabis

Article

Neuraxpharm, a leading European specialty pharmaceutical company, today announces its "Change for Health" campaign that aims to increase the acceptance of medical cannabis and provide better information to patients, physicians and pharmacies.

Based on the concept "If we turn our back on medical cannabis, we turn our back on millions of patients" Neuraxpharm is fostering a change for health across society on medical cannabis as a treatment to help improve the quality of life of hundreds of thousands of patients. With this awareness campaign, Neuraxpharm wants to encourage healthcare professionals, regulators, patients, and the public to rethink their preconceptions about cannabis and embrace it as an effective, individualized treatment option.

At the heart of the campaign 'Change for Health' stands a video to raise awareness, a dedicated website www.neuraxpharm.com/change-for-health which explains the campaign background and educational materials such as crosswords and myths and facts.

Dr. Jörg-Thomas Dierks, CEO of Neuraxpharm, commented: "Medical cannabis is still a sensitive topic surrounded by prejudices. With our campaign we want healthcare professionals, regulators, patients, and the public to rethink their perception of medical cannabis and how this treatment can help millions of patients with unmet medical needs. Because a change in our mindset towards medical cannabis will lead towards an improvement of patient's health."

Related Videos
Related Content